1570043-41-2

Basic information

• Product Name: 5-(4-(3-bromobenzyl)-5-methylthiazol-2-yl)-3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazole
• Synonyms: 5-(4-(3-bromobenzyl)-5-methylthiazol-2-yl)-3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazole
• CAS NO: 1570043-41-2
• Molecular Weight: 496.307
• Mol File: 1570043-41-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 5-(4-(3-bromobenzyl)-5-methylthiazol-2-yl)-3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazole(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(4-(3-bromobenzyl)-5-methylthiazol-2-yl)-3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazole(1570043-41-2)
• EPA Substance Registry System: 5-(4-(3-bromobenzyl)-5-methylthiazol-2-yl)-3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazole(1570043-41-2)

Safety Data

• Hazardous Substances Data: 1570043-41-2(Hazardous Substances Data)

Upstream product

• 56935-71-8 N-hydroxy-4-(trifluoromethoxy)benzimidamide 
• 1570043-40-1 4-(3-bromobenzyl)-5-methylthiazole-2-carboxylic acid 
• 1570043-39-8 ethyl 4-(3-bromobenzyl)-5-methylthiazole-2-carboxylate 
• 332-25-2 4-(trifluoromethoxy)benzonitrile 
• 1570043-38-7 3-bromo-1-(3-bromophenyl)butan-2-one 
• 1570043-37-6 1-(3-bromophenyl)-3-chlorobutan-2-one 
• 307496-31-7 (3-bromobenzyl)zinc(II) bromide 

Relevant articles and documents

HETEROCYCLIC MODULATORS OF HIF ACTIVITY FOR TREATMENT OF DISEASE

The present invention relates to compounds and methods which may be useful as inhibitors of HIF pathway activity for the treatment or prevention of cancer and other hypoxia-mediated diseases.